Occlusion Devices Market Forecast Highlighting Key Trends And Expansion Potential
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Does The Market Size Of The Occlusion Devices Market Compare Between 2026 And 2030?
The occlusion devices market has experienced robust expansion in recent years. It is anticipated to expand from $4.2 billion in 2025 to $4.6 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.6%. The historical growth of this market can be linked to a rise in cardiovascular diseases, advancements in interventional radiology, an increasing aging population, the expansion of hospital infrastructure, and the wider clinical adoption of embolization procedures.
The occlusion devices market is projected to experience robust expansion in the foreseeable future, with its valuation expected to reach $6.54 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.2%. This growth over the forecast period is attributed to several factors including an increase in neurological disorders, a rise in minimally invasive surgical procedures, ongoing technological advancements in devices, the proliferation of ambulatory care centers, and supportive reimbursement policies. Key trends anticipated during this period encompass a shift towards minimally invasive procedures, an escalating adoption of catheter-based therapies, a growing preference for embolization procedures, an increase in neurovascular interventions, and a heightened demand for high-precision occlusion devices.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/report/occlusion-devices-global-market-report
What Primary Drivers Are Shaping The Occlusion Devices Market?
The increasing need for minimally invasive techniques is projected to drive the expansion of the occlusion devices market in the future. Minimally invasive surgeries are defined as surgical methods that employ small cuts or natural bodily openings to reach and address internal structures, organs, or tissues, thereby reducing patient trauma. These techniques offer medical, financial, and aesthetic advantages that attract both patients and healthcare providers, thus fueling a rising demand across diverse medical fields. Occlusion devices are medical instruments utilized in minimally invasive procedures to obstruct or seal blood vessels, ducts, or other bodily passages. These tools are commonly employed in areas like interventional cardiology and radiology to manage conditions such as aneurysms, irregular blood flow, or congenital heart issues. As an illustration, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS) disclosed that in 2023, the overall count of aesthetic procedures neared 35 million, with surgical and non-surgical procedures combined increasing by 3.4% to total 34.9 million. Consequently, the rising demand for minimally invasive techniques propels the growth of the occlusion devices market.
What Segment Categories Shape The Occlusion Devices Market Segment Landscape?
The occlusion devices market covered in this report is segmented –
1) By Product: Occlusion Removal Devices, Embolization Devices, Tubal Occlusion Devices, Support Devices
2) By Application: Neurology, Cardiology, Peripheral Vascular Diseases, Urology, Oncology, Gynecology
3) By End User: Hospitals Diagnostic Centers And Surgical Centers, Ambulatory Care Centers, Research Laboratories And Academic Institutes
Subsegments:
1) By Occlusion Removal Devices: Thrombectomy Devices, Catheter-Based Occlusion Removal Devices, Aspiration Systems, Mechanical Clot Retrieval Systems
2) By Embolization Devices: Coil Embolization Devices, Particle Embolization Devices, Balloon Embolization Devices, Gel Embolic Agents, Liquid Embolic Agents, Stent-Assisted Embolization Devices
3) By Tubal Occlusion Devices: Essure Devices, Hysteroscopic Sterilization Systems, Fallopian Tube Clips, Tubal Ligation Devices
4) By Support Devices: Occlusion Catheters, Guidewires For Occlusion, Supportive Sheaths, Stent-Grafts For Occlusion Support
What Trends Are Affecting The Growth Of The Occlusion Devices Market?
Major companies within the occlusion devices market are prioritizing the development of innovative solutions, including advanced next-generation devices, to enhance targeted embolization procedures. A next-generation device signifies an evolved version of existing technology, delivering superior performance, augmented features, and novel capabilities. For instance, in July 2025, Embolx, a US-based medical equipment manufacturer, launched the Sniper G3 Balloon Occlusion Microcatheter, which markedly improves targeted embolization through greater efficiency, ease of use, and an extended shelf life. This third-generation device effectively doubles its shelf life to 24 months, thereby offering enhanced inventory flexibility. Developed with direct input from interventional radiologists, it boasts improved trackability and a streamlined preparation process that reduces setup time to under a minute. These advancements underscore Embolx’s dedication to physician-centered design, aiming to streamline clinical workflows and optimize procedural outcomes. The Sniper G3 is offered in all standard lengths and is prepared for global distribution, reinforcing its standing as a leading tool in embolization therapy.
Who Are The Companies Operating Across The Occlusion Devices Market Value Chain?
Major companies operating in the occlusion devices market are Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Cook Group Incorporated, Merit Medical Systems Inc., Lepu Medical Technology Beijing Co. Ltd., MicroPort Scientific Corporation, Penumbra Inc., Asahi Intecc Co. Ltd., Angiodynamics Inc., LeMaitre Vascular Inc., Elixir Medical Corporation, Vascular Concepts Ltd., Occlutech, W L Gore & Associates Inc., LifeTech Scientific Corporation, Cardiovascular Systems Inc., Venus Medtech, CeloNova Biosciences, Cordis Corporation, Pfizer Inc., Sirtex Medical Limited, Nordion Canada Inc., AtriCure Inc., Phenox GmbH, Balt Extrusion SAS
Get The Full Occlusion Devices Market Report:
https://www.thebusinessresearchcompany.com/report/occlusion-devices-global-market-report
Where Is The Occlusion Devices Market Primarily Concentrated By Region?
North America was the largest region in the occlusion devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the occlusion devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Occlusion Devices Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/occlusion-devices-global-market-report
Browse Through More Reports Similar to the Global Occlusion Devices Market 2026, By The Business Research Company
Chronic Venous Occlusions Treatment Market Report 2026
Cardiovascular Surgery Devices And Equipment Market Report 2026
Peripheral Vascular Devices And Equipment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
